Reconsider dyslipidemic medication:

Dyslipidemia, if not pharmacologically treated, seldom poses a threat to the health of a woman with diabetes during the comparatively short duration of pregnancy and, typically, the relatively few months leading up to conception. Also, there is uncertain safety of statins during pregnancy.

So, proceed to necessary modification of medication according to the following instructions:

R1.9a Discontinue statins. (1++)

R1.9b Discontinue fibrates, because of unproven safety during pregnancy. (2++)

R1.9c Bile acid-binding resins may be used, however, this is seldom warranted. (2++)

  • Another very important step in this pathway, is to distinguish co-existing thyroid dysfunction in the woman diagnosed with DM type 1 (T1DM).

Map: Management of women with diabetes mellitus (DM) in preconceptional period (295)
Node: 7680
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • Reconsider dyslipidemic medication:

Reminder

empty_reminder_msg

FINISH

Time is up